William A. Jones Jr.
Vice President, NITROMED INC.
Companies
- Apnimed, Inc.Board member Jul 30, 2026 to now1
- Annexon, Inc.Board member Jan 10, 2025 to now2
- Apogee Therapeutics, Inc.Board member Jul 13, 2023 to now3
- NewAmsterdam Pharma Co N.V.Chief Commercial Officer May 3, 2024 to Jan 7, 20254
- Akili, Inc.Board member Aug 19, 2022 to May 4, 20235
- Biohaven Pharmaceutical Holding Co Ltd.CCO-Migraine & Common Disease Apr 3, 2019 to Oct 3, 20226
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- NewAmsterdam Pharma Co N.V. NAMS43,000 shares7$872.5K at $20.29Jan 7, 2025
- Biohaven Pharmaceutical Holding Co Ltd.0 shares8Oct 3, 2022
- Apogee Therapeutics, Inc.0 shares9Sep 3, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 3, 2026Returned to company 34,824 shares of Apogee Therapeutics, Inc.9
- Jan 7, 2025Granted 43,000 shares of NewAmsterdam Pharma Co N.V.7
- Oct 3, 2022Returned to company 14,226 shares at $148.50 of Biohaven Pharmaceutical Holding Co Ltd.8
- Jan 7, 2022Shares withheld for tax 1,631 shares at $128.87 of Biohaven Pharmaceutical Holding Co Ltd.10
- Jan 7, 2022Exercised options 3,750 shares of Biohaven Pharmaceutical Holding Co Ltd.10
- Jan 6, 2022Shares withheld for tax 2,230 shares at $123.86 of Biohaven Pharmaceutical Holding Co Ltd.10
- Jan 6, 2022Exercised options 5,000 shares of Biohaven Pharmaceutical Holding Co Ltd.10
- Nov 25, 2021Shares withheld for tax 1,305 shares at $115.55 of Biohaven Pharmaceutical Holding Co Ltd.11
- Nov 25, 2021Exercised options 3,000 shares of Biohaven Pharmaceutical Holding Co Ltd.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARApnimed, Inc., Board member
- 2SEC EDGARAnnexon, Inc., Board member
- 3
- 4
- 5SEC EDGARAkili, Inc., Board member
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Jan 7, 2022
- 11SEC EDGARForm 4 filed Nov 26, 2021